SCHEMBL18749530

SCHEMBL18749530

CCC(=O)N(C)c1cccc(Cl)c1COc1ccc(C)cc1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 4/20 0.45
▸ PTGER1 P34995 1/20 0.43
▸ PTGER4 P35408 1/20 0.43
▸ PTGER3 P43115 1/20 0.43
▸ PTGER2 P43116 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ FFAR4 Q5NUL3 3/20 0.40
▸ FFAR1 O14842 2/20 0.40
▸ NR1H4 Q96RI1 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ UBE2N P61088 1/20 0.38
▸ AGPAT2 O15120 1/20 0.37
▸ LTB4R Q15722 1/20 0.37
▸ LTB4R2 Q9NPC1 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18749331 0.90 MRGPRX4 (0.47) MRGPRX4L3MBTL1FFAR4HSP90AA1UBE2N
SCHEMBL18514361 0.89 FFAR4 (0.44) MRGPRX4FFAR4FFAR1NR1H4
SCHEMBL18749516 0.89 MRGPRX4 (0.45) MRGPRX4PTGER1PTGER4PTGER3PTGER2
SCHEMBL18749683 0.89 MAPT (0.38) LTB4RLTB4R2RAB9A
SCHEMBL18749327 0.88 MRGPRX4 (0.44) MRGPRX4PTGER1PTGER4PTGER3PTGER2
SCHEMBL18749712 0.88 MRGPRX4 (0.46) MRGPRX4L3MBTL1FFAR4FFAR1HSP90AA1
SCHEMBL18749470 0.88 MRGPRX4 (0.46) MRGPRX4L3MBTL1FFAR4HSP90AA1UBE2N
SCHEMBL18749710 0.87 MRGPRX4 (0.45) MRGPRX4L3MBTL1FFAR4HSP90AA1UBE2N
SCHEMBL18749588 0.87 MRGPRX4 (0.45) MRGPRX4L3MBTL1FFAR4HSP90AA1UBE2N
SCHEMBL18749467 0.87 MRGPRX4 (0.45) MRGPRX4PTGER1L3MBTL1FFAR4HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 — — US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 — — US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 MRGPRX4 959/4885PTGER1 4793/4885PTGER4 4714/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 MRGPRX4 778/4885PTGER1 3951/4885PTGER4 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback